Answers are grounded in this paper and cite their sources.
Extracellular acidosis in relation to intracellular milieu is a unique feature of the tumor microenvironment. The difference between intracellular pH (pHi) and extracellular pH (pHe) is much larger in tumors than normal tissue. Measuring the transmembrane pH gradient (ΔpH=pHi–pHe) could provide a tool for assessing tumor aggressiveness, monitoring treatment efficacy, guiding localized drug delivery, and understanding tumor responsiveness. This work establishes transmembrane pH gradient imaging in brain tumors. We observed a significantly higher transmembrane pH gradient in RG2 tumors compared to normal brain. Decreasing transmembrane pH gradient may serve as a functional biomarker for positive therapeutic outcome.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: